Enveric Biosciences, Inc.
ENVB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000890821
No open-market purchases or sales by Enveric Biosciences, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $736.8K in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Enveric Biosciences, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- 0 vs. Q4 2021
- Shares held
- 11.0M
- +6.17M (+128.9%) vs. Q4 2021
- Total value
- $3.61M
- −$831.0K (−18.7%) vs. Q4 2021
- New holders
- 6
- 8 more added
- Sold out
- 6
- 9 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENVB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 24 | $736.8K |
| Q1 2026 | 11 | $106.6K |
| Q4 2025 | 11 | $87.7K |
| Q3 2025 | 11 | $232.6K |
| Q2 2025 | 14 | $283.2K |
| Q1 2025 | 15 | $344.7K |
| Q4 2024 | 19 | $386.7K |
| Q3 2024 | 17 | $337.2K |
| Q2 2024 | 17 | $307.3K |
| Q1 2024 | 18 | $488.4K |
| Q4 2023 | 15 | $635.8K |
| Q3 2023 | 15 | $518.3K |
| Q2 2023 | 14 | $631.1K |
| Q1 2023 | 13 | $382.4K |
| Q4 2022 | 12 | $356.8K |
| Q3 2022 | 12 | $623.0K |
| Q2 2022 | 27 | $1.99M |
| Q1 2022 | 31 | $3.61M |
| Q4 2021 | 31 | $4.45M |
| Q3 2021 | 24 | $4.64M |
| Q2 2021 | 18 | $2.72M |
| Q1 2021 | 14 | $3.42M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Enveric Biosciences, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hudson Bay Capital Management LP | 4,774,900 | $1.58M | 0.02% | +4,774,900 | New |
| Renaissance Technologies LLC | 1,990,600 | $657.0K | 0.00% | +1,436,500+259.2% | Added |
| AdvisorShares Investments LLC | 922,371 | $304.0K | 0.05% | +621,847+206.9% | Added |
| Vanguard Group Inc | 760,589 | $251.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 499,038 | $165.0K | 0.00% | −2,340−0.5% | Reduced |
| Ikarian Capital, LLC | 423,834 | $141.0K | 0.04% | +23,834+6.0% | Added |
| Mirae Asset Global Investments Co., Ltd. | 286,267 | $94.0K | 0.00% | −106,653−27.1% | Reduced |
| Virtu Financial LLC | 276,184 | $91.0K | 0.01% | +135,474+96.3% | Added |
| Susquehanna International Group, LLP | 176,363 | $58.0K | 0.00% | +155,758+755.9% | Added |
| Geode Capital Management, LLC | 166,537 | $54.0K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 107,500 | $35.0K | 0.00% | −31,400−22.6% | Reduced |
| UBS Group AG | 97,904 | $32.0K | 0.00% | +83,938+601.0% | Added |
| State Street Corp | 90,634 | $30.0K | 0.00% | +1,748+2.0% | Added |
| Citadel Advisors LLC | 58,332 | $20.0K | 0.00% | −96,805−62.4% | Reduced |
| Group One Trading, L.P. | 52,283 | $17.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 44,160 | $15.0K | 0.00% | 00.0% | Unchanged |
| Warberg Asset Management LLC | 45,000 | $15.0K | 0.00% | +45,000 | New |
| Northern Trust Corp | 36,504 | $12.0K | 0.00% | 00.0% | Unchanged |
| Scotia Capital Inc. | 27,272 | $9.00K | 0.00% | −38,883−58.8% | Reduced |
| Engineers Gate Manager LP | 25,824 | $9.00K | 0.00% | −7,028−21.4% | Reduced |
| Tower Research Capital LLC (TRC) | 20,314 | $7.00K | 0.00% | +20,314 | New |
| Creative Planning | 17,577 | $6.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 16,765 | $6.00K | 0.00% | +16,765 | New |
| Integrated Wealth Concepts LLC | 10,801 | $4.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 11,419 | $4.00K | 0.00% | +11,419 | New |
| Cutler Group LP | 5,600 | $1.00K | 0.00% | −300−5.1% | Reduced |
| Advisor Group Holdings, Inc. | 4,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 971 | $0 | 0.00% | −2,187−69.3% | Reduced |
| Wells Fargo & Company | 972 | $0 | 0.00% | +68+7.5% | Added |
| Morgan Stanley | 1 | $0 | 0.00% | −1−50.0% | Reduced |
| Royal Bank of Canada | 1,039 | $0 | 0.00% | +1,039 | New |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −742,046−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −58,915−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −42,050−100.0% | Sold out |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −26,268−100.0% | Sold out |
| Rinkey Investments | 0 | $0 | 0.00% | −6,500−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |